Symbol Name ID |
Kat5
K(lysine) acetyltransferase 5 MGI:1932051 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
\Cdkn2atm1Cjs/\Cdkn2a+ \Kat5tm1Jwl/\Kat5+ involves: 129S1/Sv * 129X1/SvJ * C57BL/6 |
decreased tumor latency | J:125164 |
\Kat5tm1Jwl/\Kat5+ \Trp53tm1Tyj/\Trp53tm1Tyj involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 |
increased tumor incidence | J:125164 |
\Kat5tm1Jwl/\Kat5+ \Tg(IghMyc)22Bri/0 involves: 129S1/Sv * 129X1/SvJ * C57BL * C57BL/6 * SJL |
abnormal B cell physiology | J:125164 |
abnormal DNA repair | J:125164 | |
increased B cell derived lymphoma incidence | J:125164 | |
premature death | J:125164 | |
\Kat5tm1Jwl/\Kat5+ \Tg(IghMyc)22Bri/0 \Trp53tm1Tyj/\Trp53+ involves: 129 * C57BL * C57BL/6 * SJL |
increased B cell derived lymphoma incidence | J:125164 |
premature death | J:125164 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 03/25/2025 MGI 6.24 |
![]() |
|